Schoeny Rita, Haber Lynne, Dourson Michael
Office of Water, U.S. Environmental Protection Agency, ML4301, 1200 Pennsylvania Avenue NW, Washington, DC 20460, USA.
Toxicology. 2006 Apr 17;221(2-3):217-24. doi: 10.1016/j.tox.2006.01.019. Epub 2006 Feb 17.
There are several pieces of legislation based on human health assessment that set the framework for U.S. EPA's regulation of water contaminants, such as bromate. The Safe Drinking Water Act, for example, specifies that the best available science be used in support of regulation of drinking water contaminants, and highlights that regulations must provide protection to sensitive human populations. Recent EPA guidance, including the 2005 Cancer Guidelines, emphasize analyzing data, and using defaults only in the absence of adequate data. This represents a major shift from the former practice of invoking default methodologies or values unless it was judged that there were sufficient data to depart from them. The Guidelines further present a framework for assessing data in order to determine if a mode of action (MOA) can be established, based on a modification of the Bradford-Hill criteria for causality. A similar approach is used by the International Programme on Chemical Safety (IPCS). To illustrate the application of the framework for evaluating animal tumors, three case studies are considered here. In the first example (chloroform carcinogenicity), sufficient data exist to identify the MOA in animals, and the data are used to illustrate the evaluation of the plausibility of the animal MOA in humans, taking into account toxicokinetics and toxicodynamics. In this case, the MOA was judged to be relevant to humans, and was used to determine the approach for the cancer quantitation. In the second example (naphthalene inhalation carcinogenicity), the key question is whether the weight of evidence (WOE) is sufficient to establish the MOA in animals. Atrazine-induced mammary tumors form the final example, illustrating the reasoning used to determine that the tumor MOA in animals was not considered relevant to humans; atrazine is therefore considered not likely to be a human carcinogen.
有几部基于人类健康评估的法规为美国环境保护局(EPA)对水污染物(如溴酸盐)的监管设定了框架。例如,《安全饮用水法》规定应使用现有最佳科学依据来支持对饮用水污染物的监管,并强调法规必须为敏感人群提供保护。EPA最近的指南,包括2005年癌症指南,强调要分析数据,仅在缺乏充分数据时才使用默认值。这与以前的做法有重大转变,以前除非判断有足够数据可以偏离,否则会采用默认方法或值。这些指南还提出了一个评估数据的框架,以便基于对布拉德福德 - 希尔因果关系标准的修改来确定是否可以建立作用模式(MOA)。国际化学品安全规划署(IPCS)也采用了类似方法。为说明评估动物肿瘤框架的应用,这里考虑三个案例研究。在第一个例子(氯仿致癌性)中,有足够数据来确定动物中的作用模式,这些数据用于说明考虑毒代动力学和毒效动力学后对人类中动物作用模式合理性的评估。在这种情况下,该作用模式被判定与人类相关,并用于确定癌症定量方法。在第二个例子(萘吸入致癌性)中,关键问题是证据权重(WOE)是否足以确定动物中的作用模式。阿特拉津诱导的乳腺肿瘤构成最后一个例子,说明用于确定动物中的肿瘤作用模式与人类不相关的推理过程;因此阿特拉津被认为不太可能是人类致癌物。